Credits: Canva
An experimental treatment happens to be the solution to delay Alzheimer's symptoms in some people. These people are the ones who are genetically destined to get the disease in their 40s or 50s. These new findings form ongoing research has now been caught up in Trump administration funding delas. The early results of the study has been published on Wednesday and the participants too are worried that politics could cut their access to a possible lifeline.
One of the participants had said, "It is still a study but it has given me an extension to my life that I never banked on having." The participant is named Jake Henrichs, form New York City, who is 50 years old. He is one of them to be treated in that study for more than a decade now and has remained symptom-free despite inheriting an Alzheimer's-causing gene that had killed his father and brother around the same age.
Two drugs which can modestly slow down early-stage Alzheimer's are sold in the United States. These drugs clear the brain of one of its hallmarks, a sticky gunk-like part called the amyloid. However, there have not been any hints that removing amyloid far earlier, way many years before the first symptoms appear, may postpone the disease.
The research is led by Washington University in St Louis, which involved families that passed down rare gene mutation as participants. This meant it was almost guaranteed that they will develop symptoms at the same age their affected relatives did.
The new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset. The study is published in the journal Lancet Neurology.
Washington University's Dr Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes says, "What we want to determine over the next five years is how strong is the protection. Will they ever get the symptoms of Alzheimer’s disease if we keep treating them?”
The researchers before though did not know what exactly caused Alzheimer's which affects nearly 7 million Americans, most of them in their later life. However, it is clear that these silent changes occur in the brain at least two decades before the first symptom shows up. The big contributor. At some point amyloid buildup can trigger a protein named tau that then starts to kill neurons, which can lead to cognitive decline.
Researchers are now thus studying the Tau-fighting drugs and are looking into other factors, like inflammation, brain's immune cells and certain virus.
The National Institute of Health (NIH) has expanded its focus as researchers have found more reasons for Alzheimer's. In 2013, the NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs over a third targeting amyloid. By last fall, there were 68 drugs and 18% of them target amyloid. However, there are scientists too who think that amyloid is not everything and their is way more in the brain tissue, immune cells, and more which can be studied.
Credit: AI
The FSSAI recently issued notices to three food business operators over what it described as misleading claims and labelling violations. The companies that have received notices are Heritage Foods Ltd for its paneer, Dia Foods for La Casa Vegan Hazelnut Chocolate Spread, and Cipzer Nutraceuticals for its juice capsules.
The food regulatory body directed the companies to provide explanations within seven days why action should not be initiated under the Food Safety and Standards Act, 2006.
The move is part of the regulator's broader ongoing crackdown on deceptive food packaging and marketing claims aimed at protecting consumers.
Also read: FSSAI Targets 6 Energy Drink Brands; Experts Link Them to Obesity, Liver Problems
FSSAI issued a notice to Heritage Foods, objecting to the use of the term “Fresh Paneer” on the packaging. It stated that the claim term does not meet the conditions laid down under Schedule V governing the use of the word “fresh”.
According to the regulator, the label “Fresh Paneer” is liable to mislead consumers because it does not satisfy the prescribed criteria for using the term.
FSSAI also issued a notice to Dia Foods over its La Casa Vegan Hazelnut Chocolate Spread, alleging that several claims displayed on the packaging could mislead consumers. Among the claims questioned are:
The regulator further pointed out that the product uses the phrase "100% Organic & Vegan”, which could be misleading as it has not obtained approvals like organic and vegan food.
Further, according to FSSAI, the packaging does not display the mandatory organic certification marks, including the Jaivik Bharat logo required under Indian regulations.
It also objected to its use of “100%” as the food regulatory body has stated that it cannot be defined under FSS Act, 2006.
Also read: Popular Biscuit Brand Under FSSAI Scrutiny For Misleading ‘100% Atta’ & ‘No Added Sugar’ Claims
A third notice was issued to Cipzer Nutraceuticals over its juice capsules. FSSAI said the product carries claims that violate food labelling and advertising regulations.
In its notice, it said that the product carried the claim “FSSAI-approved” which could imply that FSSAI specifically endorsed it.
Other reasons listed in the complaint stated that the product boasted of claims like “Boost your immune system” and “remove toxins from your body”, which had no scientific backing. It also said the product’s packaging depicted pictures of various vegetables that were listed in the ingredient list.
The regulatory body added that the product also claimed the presence of Vitamin C and Vitamin E but failed to substantiate it scientifically.
The makers also claimed that the capsules are “made from organic vegetables”. FSSAI said that it could mislead the consumers as it does not carry the prescribed organic certification, including Jaivik Bharat Logo.
The latest notices are part of FSSAI's ongoing crackdowns against misleading food claims. In recent weeks, the regulator has issued notices to several food companies over the use of terms like “100%,” “healthy,” “organic,” “natural,” and “fresh” as they do not comply with food labelling and advertising regulations.
The regulator has maintained that such claims can influence consumer purchasing decisions and must be scientifically substantiated and legally compliant.
Prominent brands that faced FSSAI scrutiny includes Red Bull Energy Drink, PepsiCo – Adrenaline Rush Energy Drink, Reliance Consumer Products – Campa Energy Gold Boost, Sting Energy Drink, Hell Energy, Coca-Cola-backed Monster, Eat Fit Digestive Biscuits, Emami (Healthy & Tasty), Health Aid, Troovy, The Healthy Factory, Healthy Master, Healthy Choice, Plan B Foods, and Neuherbs.
Also read: FSSAI Tightens Food Safety Norms, Mandates Food-Grade Knives, Cutting Tools
HealthandMe had reported food contamination from Indore's Bhagirathpura, the same place that was the epicenter of water contamination that claimed many lives. HealthandMe also reported the news of Horlicks adulteration in Odisha.
In another news, bacteria were found in Amul milk packages, along with Mother Dairy and Country Delight. Eggoz, too, landed in a controversy, when a YouTube video went viral claiming that the sample tested positive for Nitrofuran.
MicrobioTx, a Bengaluru-based gut health startup, tested samples from urban populations across 9 Indian states and 14 cities and found that people are significantly exposed to pesticides, insecticides, antibiotics, steroidal growth regulators, and forever chemicals.
The independent study reported the following findings:
Credit: US CDC
The cyclospora parasite outbreak in the US is continuing to grow, with cases nearing 900, according to local health officials.
While infections have been reported in about 18 states, Michigan and Ohio continue to see the highest number of cases of the intestinal infection.
As of July 6, 678 cases of cyclosporiasis had been confirmed, an official from the Michigan Department of Health and Human Services (MDHHS) told ABC News. This is an increase from roughly 300 cases reported last week. The state annually records up to 50 cases, but the current outbreak is about 13.5 times higher than average.
According to Dr. Natasha Bagdasarian, an infectious disease physician, epidemiologist, and the chief medical executive for the state of Michigan, the figure is a "moving target," meaning cases are likely to continue rising.
"There is a significant lag time between exposure to contaminated produce or contaminated materials and development of symptoms," she told ABC News. "So it can take a week, sometimes even two weeks between exposure and development of symptoms."
In Ohio, there were 177 cases of cyclosporiasis as of July 2, Ken Gordon, press secretary for the Ohio Department of Health's communications office, was quoted as saying.
Cases have been confirmed across 43 counties in Ohio so far this year, according to Gordon. Nearly 171 cases have been reported since June 20.
Meanwhile, the Centers for Disease Control and Prevention (CDC) reported that 145 cases had been detected in 17 states since May 1, excluding Michigan, as of June 16, with at least 20 people hospitalized. No deaths have been reported.
The CDC said cases ranged in age from 5 to 86 years, with a median age of 42. About 61 per cent of patients were female.
So far, no cases have been linked between states, and health officials are still investigating whether there is a common source of the outbreak in Michigan.
Also read: Cyclospora Parasite Spreads to More US States: Foods to Avoid Right Now
The CDC recommends following safe food handling practices to reduce the risk of infection:
The parasite spreads through food or water contaminated with human feces and is not spread directly from person to person.
According to Dr. Darien Sutton, an emergency medicine physician, proper handwashing is very important.
"This type of parasite doesn't easily go away with alcohol-based hand sanitizer. So, good old handwashing is really key here," said the ABC News medical correspondent.
Cyclospora cayetanensis is a parasite that causes cyclosporiasis, a form of food poisoning.
People can become infected through contaminated food or water. The infection causes watery diarrhea and other intestinal symptoms.
A Cyclospora infection can be mild or severe and may last for weeks or even months. It is typically treated with antibiotics.
People with weakened immune systems, such as those with HIV/AIDS or cancer, are at greater risk of severe disease.
Symptoms of cyclosporiasis usually begin within a week of exposure to contaminated food or water and include:
Credit: AI
The launch of the weight-loss drug Wegovy has sparked fresh concerns among pharmacists in the UK, who warn that the new tablet format could make it easier for manufacturers to produce and sell counterfeit medicines.
The once-daily semaglutide pill, developed by Novo Nordisk, recently became available through private high street and online pharmacies after receiving approval from the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
While the pill is expected to help patients who are reluctant to use injections, experts fear it may also increase the risk of a growing black market for fake weight-loss drugs.
According to a survey conducted by the National Pharmacy Association (NPA) with 310 pharmacies, 97% believe that the weight loss tablet could lead to an increase in counterfeit products being sold unlawfully.
Olivier Picard, chairman of the National Pharmacy Association said, “As this survey shows, pharmacies are concerned about a dangerous and growing black market for weight loss medicines, with tablet form of medication likely to be easier for criminals to counterfeit.”
He said that all patients must visit an authorised pharmacy for Wegovy pills.
He added: “Patients should only ever obtain weight loss medication from a regulated pharmacy after an appropriate consultation with a healthcare professional. Fake medicines pose a serious risk to health because they may contain harmful ingredients or incorrect doses.”
Also read: Wegovy Weight Loss Pill Available in UK Pharmacies From Today: All You Should Know
Unlike injectable medications of GLP-1, tablets often require less sophisticated manufacturing equipment, which makes it easier to make counterfeits.
As the medicated weight loss market is rising after the popularity of GLP-1 medications increased, criminals can produce fake pills on a large scale, using simple equipment.
Counterfeit GLP-1 medicines have already become a growing global concern. In September 2025, the European Medicines Agency (EMA) said that there had been a sharp rise in illegal forms of semaglutide and other GLP-1 medicines online.
The agency also warned that these fake medicines may contain no active ingredient, improper doses, or harmful substances that can lead to failure of treatment or serious health complications.
Demand for GLP-1 medicines such as Wegovy and Mounjaro has soared worldwide as studies continue to demonstrate significant weight loss benefits.
Also read: Can Ozempic-Like GLP-1 Drugs Slow Aging, Boost Longevity?
Clinical trials of the oral Wegovy tablet have shown participants taking the highest dose lost approximately 14% to 17% of their body weight over 64 weeks when combined with diet and exercise. However, pharmacists say the popularity of these treatments has also created opportunities for fraudsters.
Experts urge consumers to avoid purchasing weight-loss medicines from unofficial online sellers or social media advertisements, regardless of how attractive the prices appear.
Genuine GLP-1 medicines require a medical consultation and prescription, and authorised pharmacies carry out necessary clinical checks before selling them.
The semaglutide (Wegovy) tablet is the first oral glucagon-like peptide-1 (GLP-1) medicine approved in the UK for weight loss.
It can be prescribed alongside a reduced-calorie diet and increased physical activity for adults who have obesity (BMI of 30 or above), or are overweight (BMI between 27 and 30), and have at least one weight-related comorbidity
© 2024 Bennett, Coleman & Company Limited